chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Post vax, pt immediately had dizziness with shortness of breath, light-headedness, fatigue, numbness to bilateral legs and feet and tightness in chest. Pt felt like he was going to pass out. IV drip started, oxygen given and called 911. Sent to ER. Had the same reaction after Hep-A was given.
A 102 year old male patient had received the first dose of Shingrix on  11SEP2019 and  had not yet received the second dose of Shingrix.; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 102-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received on 11th September 2019).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report. Till the time of reporting, the patient did not receive the 2nd dose of Shingrix as per the vaccination schedule, which led to incomplete course of vaccination. No further events were reported.  The reporter agreed to be contacted for follow up. The Vaccine Administration Facility is the same as Primary Reporter.
The vial expired on 05-May-2022, was moved to fridge on 29-Apr-2022 and was administered on 06-May2022; Nine people vaccinated with the expired vaccine; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Nine people vaccinated with the expired vaccine) and PRODUCT STORAGE ERROR (The vial expired on 05-May-2022, was moved to fridge on 29-Apr-2022 and was administered on 06-May2022) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 084J21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-May-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Nine people vaccinated with the expired vaccine). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial expired on 05-May-2022, was moved to fridge on 29-Apr-2022 and was administered on 06-May2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Nine people vaccinated with the expired vaccine) and PRODUCT STORAGE ERROR (The vial expired on 05-May-2022, was moved to fridge on 29-Apr-2022 and was administered on 06-May2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient received booster dose on 06-May-2022. Concomitant medication list was not provided. Nine people were vaccinated on 06-May-2022.The vial was moved from the freezer to the fridge on 29-Apr-2022. The vial did not undergo any temperature excursions.  Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 11-May-2022: Followup received with Updated narrative. On 11-May-2022: Followup received with added refrigeration date of the vial in the narrative.
Chicken Pox outbreak: Fatigue, nausea, stomach pain, headaches, fevers, breakouts over several days resulting in appx 100 bumps, itching, body aches. Prescribed Valtrex.
pt recv vax 10OCT96 & 11OCT95 pt devel severe swelling radiating in both directions from the site of inj;pt recovered from sx on 16OCT96;
Headaches- Intense and consistently reoccurring-  most prominent at both temples on head and sometimes start on top of head, both sides all the way down the neck-  have had now for 3 months- started day after 2nd vaccine on 2/17/21  Constipation- started the week after 2nd vaccine (2/17/21) and had not resolved- have had to use stool softners, laxatives and now prescription (Linzess) to regulate  Orthostatic Hypotension-  Diagnosed on 4/25/21 after he fainted, lacerated his head and ended up in ER.  Fell one more time (4/27/21) and went to ER again.  Is now unable to stand more than 2-3 minutes before fainting.  Cardiologist ran heart stress test on 5/4/21 and we are awaiting results.
1 week after getting vaccine, pt had numbness of nerve that goes under left side of ribcage. No blisters. Some itching and some tingling. Itched for 1 week. All symptoms then disappeared without treatment.  02/12/2010 Information has been received from a 60 year old female with no medical history or allergies who in fall 2007 was vaccinated with 0.65 ml dose of ZOSTAVAX. Concomitant therapy included MOBIC, NEXIUM, MSD and diabetic medications (unspecified). In 2007, about 3 weeks after vaccination the patient experienced itching from middle of back to abdomen for about 10 days. The patient also stated that her husband had shingles in the past and took Rofecoxib which cured the shingles. No diagnostic laboratory tests were under taken. At the time of report the patient had recovered. Unspecified medical attention was sought. A product quality complaint was not involved. Follow-up information received from VAERS (Temp, VAERS E-Report Number E21047) indicating that the patient has a drug hypersensitivity to codeine, benign essential hypertension, gastroesophageal reflux disease, type 2 diabetes mellitus, postmenopause and colonic polyp, who on 27-Sep-2007 the patient received a dose of ZOSTAVAX (lot# 654604/1406P) subcutaneously in the left arm. Concomitant therapy included MOBIC, NEXIUM, losartan potassium-HCTZ, sitagliptin phosphate and alavastatin. On 03-Nov-2007, the patient had numbness of nerve that goes under left side of ribcage. No blisters, some itiching and tingling. Itched for one week. All symptoms then disappeared without treatment. Additional information has been requested.
Tinius. Ringing in ears that is getting slightly worse.  (Don't plan to get 2nd shot as a result)
Patient reported "felt hot", confusion, tingling to right hand and forearm, itching, "felt winded"
Patient complains of pain and swollen R arm. As per pt she received the pneumonia vaccine yesterday and her arm is really hurting and swollen and seems like it's getting worse.   Per pt she iced the area but it's still really painful.  She was seen by urgent care and placed on antibiotics as a precaution.   Pt sent message to her PCP on 3/13/2023 (Monday morning) stating "My arm swelled up almost double so they gave me antibiotics for some reason. Then yesterday the swelling finally went down but then I got so sick. Threw up and fever all night. I'm much better now though. Anyway they shouldn't give that shot to people. Could you please report it to the manufacturer so they know what it is doing to people. I was in so much pain. Thanks" Pt was placed on nurse triage schedule but has not respond to calls placed to her.
Full body aches, fever to 101, shivers,  runny nose  Tylenol and Advil
fever (100.3), headache,backache,chills,shaking,nausea  approx. 5.5 hours after dose. morning after fever (99.0), no shaking, no chills, back still sore.
An anonymous single patient print was received from the MCA on 11/26/01, regarding a 4 year old male patient who experienced wheeze, stridor and loss of voice on 10/16/01 after receiving Fluvirin vaccine (batch 760169) on the same day. The patient's medical history included asthma and the patient was receiving Prednisolone, ipratropium and budesonide. The events resolved on the same day. Therapeutic measures included dexamethasone po and salbutamol nebulizer. There was insufficient information to determine the reporter's causality assessment.
Shingles often even got the shot/Suspected vaccination failure; shingles in scalp, jaw, chest and groin; very painful; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and pain. On an unknown date, the outcome of the vaccination failure, shingles and pain were unknown.   It was unknown if the reporter considered the vaccination failure, shingles and pain to be related to Shingles vaccine.  Additional details were provided as follows:  The patient self-reported this case.  The age at vaccination was not reported. The patient got the Shingle shot and often got shingles. The patient reported that his/her shingles attack on scalp, jaw, chest and groin and it was very painful. This case was considered as suspected vaccination failure since the details regarding completion of primary immunization schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting. The follow-up would not possible as no contact details were available
Area was very warm to touch, swollen, red, very painful x's 7 days. Tx- cold cloth tx, ADVIL or BENADRYL advised. If fever presents go to ER.
My throat was swollen and it caused me to cough a lot for about 8 days. I had a slight fever for about 2 day. I contacted my doctor. He called in a prescription for amoxicillin. Then, I started sneezing and running nose.
Patient complained of sore arm after shot and was told to ice the arm. She did not complain months later as she came to pick up medication every month. However this fall she said her arm started to hurt again due to the cold and reported pain radiating down her arm to her finger tips. She saw her doctor and he told her that it was probably due to the vaccination being given too high in the shoulder. She came and reported it to the pharmacist.
Drug ineffective; COVID 19 positive; headache; fatigue; some dizziness; mild sore throat; some mild congestion; some variable mild coughing; Booster; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administration date Sep2021 (Batch/Lot number: unknown) as dose number unknown (booster), single for covid-19 immunisation. Relevant medical history included: "Type 1 diabetes" (ongoing); "celiac" (ongoing); "Hashimoto's" (ongoing). Concomitant medication(s) included: INSULIN (ongoing); LEVOTHYROXINE (ongoing). Vaccination history included: Covid-19 vaccine (MANUFACTURER UNKNOWN), for COVID-19 Immunization. The following information was reported: DRUG INEFFECTIVE (medically significant) with onset 03Jan2022, outcome "unknown", described as "Drug ineffective"; COVID-19 (medically significant) with onset 03Jan2022, outcome "unknown", described as "COVID 19 positive"; IMMUNISATION (medically significant) with onset Sep2021, outcome "unknown", described as "Booster"; HEADACHE (non-serious) with onset 31Dec2021, outcome "unknown", described as "headache"; FATIGUE (non-serious) with onset 31Dec2021, outcome "unknown", described as "fatigue"; DIZZINESS (non-serious) with onset 31Dec2021, outcome "unknown", described as "some dizziness"; OROPHARYNGEAL PAIN (non-serious) with onset 31Dec2021, outcome "unknown", described as "mild sore throat"; NASAL CONGESTION (non-serious) with onset 31Dec2021, outcome "unknown", described as "some mild congestion"; COUGH (non-serious) with onset 31Dec2021, outcome "unknown", described as "some variable mild coughing". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (03Jan2021) positive, notes: COVID 19 positive via rapid test yesterday 03Jan2022. Clinical course: COVID 19 positive via rapid test yesterday 03Jan2022 and symptoms starting Friday prior. Have been vaccinated and had the booster end of Sep2021. So far COVID symptoms mild (headache, fatigue, some dizziness, mild sore throat, some mild congestion, some variable mild coughing). Optional Information: Type 1 diabetes, celiac, hashimoto's are underlying conditions. Currently taking insulin and levothyroxine.  The lot number for bnt162b2 was not provided and will be requested during follow up.
Tingling, numbness,  started in my left arm, now I?m my right arm, and foot
This spontaneous report was received from a pharmacist refers to a 74 year old female patient. The patients pertinent medical history was unknown, the patient had no known allergies. On 05-OCT-2013, the patient was vaccinated with a dose of 0.65 ml ZOSTAVAX (lot number J004270, expiry date 12-JUL-2014), subcutaneous in the back of right arm. Concomitant therapies included AFLURIA was given 2 weeks before ZOSTAVAX on an unspecified anatomical site. On 05-OCT-2013, the patient noticed some blood at the injection site of the right arm. The patient now had a red ring at the injection site of the right arm with a red streak going down her right arm. There was no treatment rendered for the events. The outcome of the reported events were not recovered. The patient sought medical attention. Additional information has been requested.
This case was reported by a consumer via call center representative and described the occurrence of injection site bruising in a 52-year-old female patient who received SHINGRIX for prophylaxis. Concomitant products included FLONASE, Albuterol, Aspirin, Atorvastatin, diazepam, Hydroxyzine, levetiracetam, diphtheria toxoid + tetanus toxoid (Td), hydrochlorothiazide and Oxycodone + Apap. On 21st May 2018, the patient received the 1st dose of SHINGRIX (intramuscular). On an unknown date, less than a month after receiving SHINGRIX, the patient experienced injection site bruising, injection site discoloration, injection site burning, injection site swelling and injection site itching. On an unknown date, the outcome of the injection site bruising, injection site burning, injection site swelling and injection site itching were recovered/resolved and the outcome of the injection site discoloration was not recovered/not resolved. The reporter considered the injection site bruising, injection site discoloration, injection site burning, injection site swelling and injection site itching to be related to SHINGRIX. Additional details were provided as follows: The concomitant medication included high BP pill and potassium. The reporter stated that her friend received SHINGRIX on left arm at 9:00. In 2018, after the vaccination, the site was bruised, swollen and itched really bad. The itching turned into a burning sensation, and then it started growing into a large dark spot on her arm. The swelling, itching and burning lasted for one week before resolving, but the dark spot was still there and had not gotten any better.
No additional information available. No additional adverse events.; Caller is medical assistant requesting four doses administered of improperly stored MMR II.; This spontaneous report was received from a medical assistant, referring to a patient of unknown age and gender.  The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On 28-JUL-2022, the patient was vaccinated with an improperly storage dose of measles, mumps, and rubella (WISTAR RA 27-3) virus vaccine, live (M-M-R II) rHA (valid lot #U022174, expiration date: 14-JUL-2023) (strength, anatomical location and route of administration were not provided) for prophylaxis. Temperature excursion was at 10.1 degree Celsius (C) for 15 minutes. No previous temperature excursion occurred. No additional information adverse events were reported.  This is one of several reports with the same reporter (captured in MARRS# 2208USA003290, MARRS# 2208USA003578, and MARRS# 2208USA003711).; Sender's Comments:  US-009507513-2208USA003290: US-009507513-2208USA003578: US-009507513-2208USA003711:
Malaise; Chills; Bain fog; Red rash all over body; Fever of 101.4; Head ache; Body aches; Felt like worst flu ever; This case was initially received via an unknown source (no reference has been entered for a health authority or license partner) on 18-Mar-2021. The most recent information was received on 25-Jul-2021 and was forwarded to Moderna on 25-Jul-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Body aches), INFLUENZA LIKE ILLNESS (Felt like worst flu ever), FEELING ABNORMAL (Bain fog), RASH (Red rash all over body) and PYREXIA (Fever of 101.4) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031A21A. and 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Penicillin allergy, Allergy to antibiotic (Amoxacillin), Allergy to antibiotic (tetracycline) and Allergy to antibiotic (erythromycin). Concomitant products included PRAVASTATIN for Cholesterol, BISOPROLOL for Heart rate, ENALAPRIL MALEATE, HYDROCHLOROTHIAZIDE (VASOPRIL PLUS), ATORVASTATIN, VITAMINS NOS and ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for an unknown indication.   On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-Mar-2021, the patient experienced PAIN (Body aches), INFLUENZA LIKE ILLNESS (Felt like worst flu ever), PYREXIA (Fever of 101.4) and HEADACHE (Head ache). On 18-Mar-2021, the patient experienced FEELING ABNORMAL (Bain fog) and RASH (Red rash all over body). On an unknown date, the patient experienced MALAISE (Malaise) and CHILLS (Chills). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency; IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. On 17-Mar-2021, PAIN (Body aches), INFLUENZA LIKE ILLNESS (Felt like worst flu ever), PYREXIA (Fever of 101.4) and HEADACHE (Head ache) had resolved. At the time of the report, FEELING ABNORMAL (Bain fog), RASH (Red rash all over body), MALAISE (Malaise) and CHILLS (Chills) was resolving.            Heart racing and slowing down (Start Date 16-Mar-2021  and Stop Date 17-Mar-2021) Allergic to IV contrast.   This case was linked to MOD-2021-049483 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 25-Jul-2021: Significant follow-up (New events added), Patient demographic details, Concomitant drugs, Facility details and Outcome updated
Sick/looked like dead; Injection site itching/Red mark and Itching; Injection site pain; Injection site redness/Red mark and Itching; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Sick/looked like dead), INJECTION SITE PRURITUS (Injection site itching/Red mark and Itching), INJECTION SITE PAIN (Injection site pain) and INJECTION SITE ERYTHEMA (Injection site redness/Red mark and Itching) in an adult female patient who received mRNA-1273 (Spikevax) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Rheumatoid arthritis.    No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form On an unknown date, received second dose of mRNA-1273 (Spikevax) (Intramuscular) dosage was changed to 1 dosage form and ADALIMUMAB (HUMIRA) (Subcutaneous) Citrate Free. and ADALIMUMAB (HUMIRA) (Subcutaneous) dosage was changed to Citrate Free. On an unknown date, the patient experienced ILLNESS (Sick/looked like dead), INJECTION SITE PRURITUS (Injection site itching/Red mark and Itching), INJECTION SITE PAIN (Injection site pain) and INJECTION SITE ERYTHEMA (Injection site redness/Red mark and Itching). At the time of the report, ILLNESS (Sick/looked like dead), INJECTION SITE PRURITUS (Injection site itching/Red mark and Itching), INJECTION SITE PAIN (Injection site pain) and INJECTION SITE ERYTHEMA (Injection site redness/Red mark and Itching) outcome was unknown.            No concomitant medication was reported. It was unknown if patient was enrolled in a COVID-19 Vaccine Trial. No treatment medication was reported.  The reporter causality for the events of sick/looked like dead, injection site pain, red mark and itching with Humira was not reported.
By 8pm of the day I received the Covid-19 booster (Moderna), I became chilly and achy.  My temperature was 100°F.  I felt very tired and had a headache at the bae of my head.  I didn?t sleep well.  I felt poorly the next day, as well.  My temperature spiked to 100.5°F later that afternoon.  I slept well?9.8 hours.  I felt better upon awakening, but I am still a bit tired today.  No fever and no headache.
she broke into a rash but not in the site of injection; This spontaneous case was reported by a patient and describes the occurrence of RASH (she broke into a rash but not in the site of injection) in a female patient of an unknown age who received mRNA-1273.815 (SPIKEVAX 2023-2024) (batch no. ASKU) for COVID-19 prophylaxis.     No Medical History information was reported.    On 06-Oct-2023, the patient received dose of mRNA-1273.815 (SPIKEVAX 2023-2024) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH (she broke into a rash but not in the site of injection). At the time of the report, RASH (she broke into a rash but not in the site of injection) outcome was unknown.        The action taken with mRNA-1273.815 (SPIKEVAX 2023-2024) (Unknown) was unknown.   For mRNA-1273.815 (SPIKEVAX 2023-2024) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  It was reported as unknown that patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine. The patient reported that after moderna vaccine, broke into a rash but not in the site of injection but below on the arm. Patient wanted to know is it a normal side effect from the vaccine to have a rash in a site different than site of injection. No treatment medications were reported.   Reporter did not allow further contact
Patient was administered a second booster dose of Pfizer COVID-19 vaccine today, 12/28/21, after having already received his booster dose on 12/07/21. Patient was monitored for 15 minutes without any signs of adverse reactions.
Post immunization and off-site, vaccine recipient reported: headache, nausea with urge to vomit, shakiness, flu-like symptoms, sweaty, cold.
Patient received the first dose of Shingrix in her left deltoid. The next day she began experiencing muscle pain and was unable to raise her arm above shoulder level. Upon doctor visit it was discovered that vaccine had entered the bursa and caused joint lock. Doctor believes vaccine was administered to high.  Patient has since made a full recovery and has regained full range of motion in her left arm. Patient just received the second dose of the Shingrix to complete the series in her left arm and has had no reactions at this time.
Started with chest tightness, wheezing, SOB, facial redness, cough, treated with BENADRYL, steroids, inhaler, ZPAK.
Up at 2 AM , was very cold, throwing up, major chills, had a miserable next day with fever of 101.5. Had rash at injection site on 2nd day, was better on 3rd day
pt recv vax & devel a rash w/ 12 to 15 lesions;
This case was reported by a nurse via sales rep and described the occurrence of swelling arm in a female patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 2nd dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced swelling arm. On an unknown date, the outcome of the swelling arm was unknown. It was unknown if the reporter considered the swelling arm to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient said that her arm blew up after receiving the SHINGRIX. The nurse did not remember the patient's initials and did not know her date of both as well. The nurse did not agree to follow up.